NYSE · Medical - Distribution

GRDN (GRDN) Stock

$43.83 +11.05% NYSE: GRDN Healthcare

Valuation

MetricValue
Price$43.83
Market Cap$2.78B
P/E Ratio45.92
P/B Ratio11.01
P/S Ratio1.57
EPS (TTM)$0.78
52-Week High$44.00
52-Week Low$19.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE23.79%
ROA11.86%
ROCE33.49%
Gross Margin5.04%
Operating Margin5.04%
Net Margin3.64%
Debt/Equity0.17
Current Ratio1.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$792.0M$909.0M$1.0B$1.2B$1.4B
Operating Profit$30.0M$52.0M$41.0M$-63.0M$73.0M
Net Profit$16.0M$35.0M$24.0M$-87.0M$49.0M
EPS$0.27$0.58$0.39$-1.77$0.78
Op Margin3.8%5.7%3.9%-5.1%5.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$236.0M$256.0M$271.0M$321.0M$413.0M
Total Liabilities$183.0M$180.0M$211.0M$171.0M$195.0M
Cash$15.0M$1.0M$1.0M$5.0M$66.0M
Borrowings$55.0M$63.0M$69.0M$37.0M$37.0M

Latest News

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call Business Wire · Jul 15, 2026 Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last? Zacks · Jul 8, 2026 Guardian Pharmacy Services Acquires Wellness Concepts in Virginia MT Newswires · Jul 1, 2026 Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts Business Wire · Jul 1, 2026 Zacks.com featured highlights include Casey's General Stores, Everus Construction, Guardian Pharmacy Services, Expeditors International of Washington and Mama's Creations Zacks · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$58.0M$49.0M$71.0M$58.0M$100.0M
Investing Cash Flow$-22.0M$-35.0M$-28.0M$-47.0M$-52.0M
Financing Cash Flow$-13.0M$-11.0M$-16.0M$-71.0M$-30.0M
Net Cash Flow$9.0M$-14.0M$0$4.0M$61.0M
Free Cash Flow$49.0M$32.0M$56.0M$42.0M$81.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA23.57
FCF Yield3.07%
Quick Ratio1.17
Interest Coverage73.00
Return 1Y95.62%
Return 3Y—
Return 5Y—

Ownership

Insiders Held37.52%
Institutions Held58.96%
Institutions Float Held94.36%
Institutional HolderSharesReport Date
FMR, LLC2,359,3572026-03-31
Wellington Management Group, LLP1,765,1192026-03-31
Blackrock Inc.1,756,3742026-03-31
Woodline Partners LP1,306,3182026-03-31
Brown Advisory Inc.1,259,1742026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EWTX $43.52 -2.03% -14.63 $4.68B 0.00%
JANX $16.04 +0.25% -7.78 $978.19M 0.00%
MD $26.51 +0.11% 11.87 $2.18B 0.00%
MESOMesoblast Limited $18.24 +8.96% -25.86 $2.36B 0.00%
NHC $227.74 +0.73% 25.59 $3.56B 1.30%

About GRDN

GRDN stock trades at $43.83 with a market capitalization of $2.78B. The stock is valued at a price-to-earnings (P/E) ratio of 45.92, price-to-book of 11.01, price-to-sales of 1.57. Over the past 52 weeks the stock has ranged between $19.30 and $44.00, and currently trades at its 52-week high.

On profitability, GRDN generates a return on equity (ROE) of 23.79% — well above the market average, a sign of a high-quality business, return on capital employed of 33.49%, an operating margin of 5.04%, a net profit margin of 3.64%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides